Rigel Pharmaceuticals (RIGL) News Today $31.70 +1.26 (+4.14%) Closing price 08/8/2025 04:00 PM EasternExtended Trading$31.66 -0.04 (-0.14%) As of 08/8/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Why Is Rigel Pharmaceuticals Up Today?Toggle Visibility of Why Is Rigel Pharmaceuticals Up Today?Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) shares are on the rise, reflecting strong earnings results, upbeat analyst revisions and technical momentum. Key developments driving the stock include: Positive Sentiment: Zacks highlights solid upward revisions to earnings estimates for Rigel, suggesting elevated profit potential. Earnings Estimates Moving Higher for Rigel (RIGL): Time to Buy? Positive Sentiment: Zacks ranked RIGL among its #1 (Strong Buy) momentum stocks for August 8, underscoring buying interest. Best Momentum Stock to Buy for August 8th Positive Sentiment: Yahoo Finance reports Q2 results beat expectations and consensus estimates are being lifted. Results: Rigel Pharmaceuticals, Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates Positive Sentiment: Identified by Zacks as one of five stocks with strong relative price strength, highlighting resilience in volatile markets. 5 Best Stocks With Relative Price Strength to Buy Right Now Positive Sentiment: Cantor Fitzgerald sharply raised FY2025 EPS to $5.17 (from $1.20) and issued a $32 price target. Cantor Fitzgerald FY2025 Estimate Upgrade Positive Sentiment: HC Wainwright boosted Q3, Q4 and FY2025 EPS forecasts, reflecting increased confidence in upcoming quarters. HC Wainwright EPS Forecast Upgrade Positive Sentiment: Shares reached a one-year high following analyst upgrades. Rigel Pharmaceuticals Hits New 1-Year High Positive Sentiment: Zacks added RIGL to its Strong Buy list again, signaling sustained bullish sentiment. New Strong Buy Stocks for August 8th Positive Sentiment: American Banking News notes shares gapped up on an earnings beat, reflecting investor enthusiasm. Shares Gap Up on Earnings Beat Positive Sentiment: Cantor Fitzgerald lifts price target from $23 to $32, forecasting a higher trading range. Stock Price Expected to Rise, Cantor Fitzgerald Says Positive Sentiment: Technical analysis shows a “golden cross” as the 50-day SMA crosses above the 200-day SMA, a traditional bullish signal. Just Flashed Golden Cross Signal: Do You Buy? Positive Sentiment: Shares gapped up after reporting strong earnings results on August 6. Shares Gap Up After Strong Earnings Positive Sentiment: RIGL hit a fresh 52-week high, underscoring strong momentum in its share price. Hits Fresh High: Is There Still Room to Run? Neutral Sentiment: Transcript of the Q2 2025 earnings call is available for detailed insights but does not add new forward-looking information. Q2 2025 Earnings Call Transcript Overall, strong earnings performance, multiple analyst upgrades and technical indicators are underpinning RIGL’s recent stock strength.Posted 21h agoAI Generated. May Contain Errors. RIGL Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period RIGL FY2025 EPS Forecast Increased by Cantor Fitzgerald5 hours ago | marketbeat.comHC Wainwright Issues Optimistic Estimate for RIGL EarningsAugust 9 at 8:09 AM | marketbeat.comHC Wainwright Issues Positive Estimate for RIGL EarningsAugust 9 at 2:57 AM | americanbankingnews.comRigel Pharmaceuticals (NASDAQ:RIGL) Reaches New 1-Year High on Analyst UpgradeAugust 9 at 2:19 AM | americanbankingnews.comResults: Rigel Pharmaceuticals, Inc. Exceeded Expectations And The Consensus Has Updated Its EstimatesAugust 8 at 10:18 AM | finance.yahoo.comRigel Pharmaceuticals (NASDAQ:RIGL) Hits New 1-Year High Following Analyst UpgradeAugust 8 at 7:48 AM | marketbeat.comRigel Pharmaceuticals (NASDAQ:RIGL) Shares Gap Up on Earnings BeatAugust 8 at 2:45 AM | americanbankingnews.comRigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Q2 2025 Earnings Call TranscriptAugust 7 at 12:13 PM | msn.comRigel Pharmaceuticals (NASDAQ:RIGL) Stock Price Expected to Rise, Cantor Fitzgerald Analyst SaysAugust 7 at 10:56 AM | marketbeat.comRigel Pharmaceuticals (NASDAQ:RIGL) Shares Gap Up After Strong EarningsAugust 7 at 10:32 AM | marketbeat.comRigel Pharmaceuticals (NASDAQ:RIGL) Announces Earnings ResultsAugust 6 at 5:38 PM | marketbeat.comRigel (RIGL) Q2 Revenue Jumps 176%August 6 at 4:06 PM | theglobeandmail.comRigel Pharmaceuticals Inc (RIGL) Q2 2025 Earnings Report Preview: What To Look ForAugust 6 at 6:55 AM | finance.yahoo.comRigel Pharmaceuticals Inc (RIGL) Q2 2025 Earnings Call Highlights: Record Revenue and Raised ...August 6 at 2:29 AM | gurufocus.comRigel Pharmaceuticals reports Q2 EPS $3.91, consensus $1.40August 6 at 2:54 AM | msn.comRigel Pharmaceuticals, Inc. (RIGL) Q2 2025 Earnings Call TranscriptAugust 5, 2025 | seekingalpha.comRigel Pharmaceuticals, Inc. 2025 Q2 - Results - Earnings Call PresentationAugust 5, 2025 | seekingalpha.comRigel Reports Second Quarter 2025 Financial Results and Provides Business UpdateAugust 5, 2025 | prnewswire.comWith 65% institutional ownership, Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) is a favorite amongst the big gunsAugust 3, 2025 | finance.yahoo.comGSA Capital Partners LLP Makes New Investment in Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL)August 2, 2025 | marketbeat.comRigel Pharmaceuticals (RIGL) Expected to Announce Quarterly Earnings on TuesdayJuly 30, 2025 | marketbeat.comPacer Advisors Inc. Invests $2.03 Million in Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL)July 30, 2025 | marketbeat.comRigel Announces Conference Call and Webcast to Report Second Quarter 2025 Financial Results and Business UpdateJuly 29, 2025 | prnewswire.comMassachusetts Financial Services Co. MA Purchases New Holdings in Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL)July 22, 2025 | marketbeat.comRigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Receives Average Recommendation of "Hold" from BrokeragesJuly 22, 2025 | marketbeat.com38,045 Shares in Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Purchased by Jackson Creek Investment Advisors LLCJuly 19, 2025 | marketbeat.comH.C. Wainwright Reiterates a Buy Rating on Rigel Pharmaceuticals (RIGL)July 10, 2025 | insidermonkey.comRigel Pharmaceuticals, Inc. Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)July 7, 2025 | prnewswire.comRigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Given Consensus Rating of "Hold" by BrokeragesJune 27, 2025 | marketbeat.comRIGL Rigel Pharmaceuticals, Inc. - Seeking AlphaJune 24, 2025 | seekingalpha.comRigel Pharmaceuticals (NASDAQ:RIGL) shareholders have earned a 99% return over the last yearJune 21, 2025 | finance.yahoo.comRigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Stake Boosted by GAMMA Investing LLCJune 21, 2025 | marketbeat.comRigel Pharmaceuticals' SWOT analysis: promising pipeline drives stock potentialJune 14, 2025 | investing.comAssenagon Asset Management S.A. Buys 112,003 Shares of Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL)June 14, 2025 | marketbeat.comCantor Fitzgerald Weighs in on RIGL FY2026 EarningsJune 10, 2025 | marketbeat.comWellington Management Group LLP Makes New Investment in Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL)June 8, 2025 | marketbeat.comTwo Sigma Investments LP Makes New $1.03 Million Investment in Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL)June 6, 2025 | marketbeat.comRigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Shares Sold by Nuveen Asset Management LLCJune 6, 2025 | marketbeat.comMillennium Management LLC Takes $1.19 Million Position in Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL)June 5, 2025 | marketbeat.comUniversal Beteiligungs und Servicegesellschaft mbH Invests $676,000 in Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL)June 4, 2025 | marketbeat.comRigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Receives Average Rating of "Hold" from BrokeragesJune 2, 2025 | marketbeat.comSquarepoint Ops LLC Purchases 18,159 Shares of Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL)June 1, 2025 | marketbeat.comTwo Sigma Advisers LP Grows Position in Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL)June 1, 2025 | marketbeat.comRigel to Present at the Jefferies Global Healthcare ConferenceMay 28, 2025 | prnewswire.comJane Street Group LLC Has $1.05 Million Position in Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL)May 24, 2025 | marketbeat.comRigel Announces Poster Presentations at the 2025 ASCO Annual Meeting and EHA2025 CongressMay 22, 2025 | prnewswire.comSoleus Capital Management L.P. Boosts Stake in Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL)May 21, 2025 | marketbeat.com17,123 Shares in Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Acquired by Dimensional Fund Advisors LPMay 20, 2025 | marketbeat.comEnsign Peak Advisors Inc Makes New $1.44 Million Investment in Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL)May 19, 2025 | marketbeat.comJacobs Levy Equity Management Inc. Raises Stock Holdings in Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL)May 17, 2025 | marketbeat.com Get Rigel Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for RIGL and its competitors with MarketBeat's FREE daily newsletter. Email Address RIGL Media Mentions By Week RIGL Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. RIGL News Sentiment▼0.700.45▲Average Medical News Sentiment RIGL News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. RIGL Articles This Week▼264▲RIGL Articles Average Week Get Rigel Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for RIGL and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Celldex Therapeutics News Dynavax Technologies News MannKind News Innoviva News Novavax News OPKO Health News Geron News Zenas BioPharma News Lexicon Pharmaceuticals News Myriad Genetics News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:RIGL) was last updated on 8/9/2025 by MarketBeat.com Staff From Our PartnersYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Rigel Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Rigel Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.